Investors are using AI to research equities more than ever. Protect your valuation by ensuring they get the right message.
Investors are using AI to research equities more than ever. Protect your valuation by ensuring they get the right message.
Individual retail investors now own the majority of publicly-traded shares globally. Companies that engage with these investors have demonstrably lower costs of capital. However these investors are too numerous for CEOs and IR departments to engage with effectively. Generative AI chatbots like ChatGPT and Google Gemini can provide quality alternatives to social media and third-party online content. However companies have virtually no control over content on these platforms. This typically results in AI answers being generic, incomplete and often misleading. There's no substitute for speaking directly with management, and MarketMind helps companies easily generate AI content that resembles that which is provided in live meetings. Our platform makes this content available on companies web sites and a growing network of third party financial sites for additional investor exposure.
Smaller shareholders collectively control voting outcomes more than ever. MarketMind enables companies to track AI investor conversations throughout its growing network of third-party sites. MarketMind's platform uses AI to help companies identify and harness the power of this and disparate group. MarketMind's chatbot network, built by creators of the world's largest newswires, enables issuers to conduct deeply personalized, targeted proxy solicitations to smaller investors at lower cost. Its AI-based analytics engine is being designed to help existing shareholder surveillance platforms predict voting outcomes and continuously engage with stakeholders of all sizes throughout the voting process.
Retail investors increasingly want to know that their capital is going to socially-responsible companies. MarketMind's platform helps companies easily highlight their ESG initiatives and address any concerns about these initiatives' data points. This module can also be used to educate investors on relevant technical documentation including product specifications, lab test results, patient trial results, facility diagrams, geology reports, regulatory permits and asset valuation reports.
